DEXCOM, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
DEXCOM, INC. (DXCM) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$61.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-12
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2013-12-31 was $0.00.
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2013-09-30 was $0.00.
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2013-06-30 was $0.00.
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$61.20M.
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$42.40M, a 122.86% decline from fiscal 2023.
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $185.50M, a 1984.27% increase from fiscal 2022.
- DEXCOM, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $8.90M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month as first filed | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month as first filed | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month as first filed | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$61.20M 10-K · filed 2026-02-12 | ||||||
| 2024-12-31 | -$42.40M 10-K · filed 2025-02-18 | ||||||
| 2023-12-31 | $185.50M 10-K · filed 2024-02-08 | ||||||
| 2022-12-31 | $8.90M 10-K · filed 2023-02-09 | ||||||
| 2020-12-31 | -$287.20M 10-K · filed 2021-02-11 | ||||||
| 2018-12-31 | $66.60M 10-K · filed 2019-02-21 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2015-02-25 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $0.00 10-K · filed 2015-02-25 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | $0.00 10-Q · filed 2013-11-06 | $0.00 derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $0.00 10-Q · filed 2013-08-07 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $0.00 derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-01 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $0.00 derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $1.30M 10-K · filed 2015-02-25 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | $1.30M 10-Q · filed 2013-11-06 | $1.32M 10-Q · filed 2012-11-01 | $1.30M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $1.30M 10-Q · filed 2013-08-07 | $1.32M 10-Q · filed 2012-08-06 | $1.30M derived: sum of 3 quarters · filed 2014-02-20 | $1.30M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-03-31 | $1.30M 10-Q · filed 2013-05-01 | $1.32M 10-Q · filed 2012-05-02 | $1.30M derived: sum of 2 quarters · filed 2014-02-20 | $1.30M derived: sum of 3 quarters · filed 2014-02-20 | $1.30M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $0.00 derived: sum of 2 quarters · filed 2014-02-20 | $0.00 derived: sum of 3 quarters · filed 2014-02-20 | $0.00 10-K · filed 2014-02-20 | |||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $0.00 derived: sum of 2 quarters · filed 2012-11-01 | $0.00 10-Q · filed 2012-11-01 | ||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $0.00 10-Q · filed 2012-08-06 | |||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-02 | ||||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |